Enguent Jean-Pierre

Vice President, R&DSS

Enguent Jean-Pierre has filed 7 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2026. 7 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.

On the most recent filing, Enguent Jean-Pierre is listed as Vice President, R&DSS at SEALSQ Corp. Inside the rolling window, Enguent Jean-Pierre reported no open-market purchases and 6 open-market sales totaling $248K in LAES. The largest disclosed transaction in the window is a sale of 15,000 LAES shares on Jun 3, 2026, worth $53K.

Companies traded

Other insiders at LAES

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$248K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
LAESSale$36KSep 3SEC ↗
LAESSale$37KAug 5SEC ↗
LAESSale$42KJul 8SEC ↗
LAESSale$53KJun 3SEC ↗
LAESSale$47KMay 7SEC ↗
LAESSale$33KApr 9SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Enguent Jean-Pierre made?

Enguent Jean-Pierre has filed 7 SEC Form 4 filings (12 transaction rows) across 1 company since 2026.

Which companies does Enguent Jean-Pierre trade?

Enguent Jean-Pierre has filed SEC Form 4 disclosures for 1 company, including LAES.

When was Enguent Jean-Pierre's most recent SEC Form 4 filing?

Enguent Jean-Pierre's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.

What is Enguent Jean-Pierre's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Enguent Jean-Pierre is listed as Vice President, R&DSS.

What is Enguent Jean-Pierre's total buy and sell value in the current window?

Inside the rolling retention window, Enguent Jean-Pierre bought $0 and sold $248K based on SEC Form 4 filings.

What was Enguent Jean-Pierre's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 15,000 LAES shares on 2026-06-03, worth $53K, per SEC Form 4 filings.